您要查找的是不是:
- Allogeneic stem cell transplant can be a high-risk procedure. 异体干细胞移植是一种高风险的治疗过程。
- Although curative allogeneic stem cell transplantation therapy and palliative therap... 本文对地中海贫血基因治疗的研究进展做一综述。
- Allogeneic stem cell transplantation is a treatment option for certain patients. 异体干细胞移植是针对特定患者的一种治疗方法。
- An allogeneic stem cell transplant (allotransplant) may be a good treatment for some ALL patients. 巩固治疗的疗程通常持续4至6个月,维持治疗则通常持续2年。
- Objective: To explore the blood component selection and transfusion for patients undergoing major ABO-incompatible allogenic stem cell transplantation. 对ABO血型不合的异基因造血干细胞移植患者输血状况及血液成分选择进行探讨。
- The author briefs the main research progress and way of the new developed nonmyeloablative allogeneic stem cell transplantation(NAST). 简述了国内外刚刚开展的非清髓异基因造血干细胞移植(NAST)的主要研究进展和研究方向。
- In non-myeloablative transplantation therapy, patients are given mild or moderate cytotoxic treatments prior to the allogeneic stem cell infusion. 在非清髓性移植治疗中,患者在异基因造血干细胞输注前,先被施予低度或中度的细胞毒性处理。
- Allogeneic stem cell transplantation is the only treatment that can cure CML at this time.This treatment is most successful in younger patients. 异体干细胞移植是目前唯一可以治愈慢性髓细胞性白血病CML的疗法,在年轻患者中尤为成功。
- An allogeneic stem cell transplant (allotransplant) may be a good treatment for some ALL patients. Allotransplants are explained beginning on page 15. 同种异体干细胞移植(同种异体移植物)对一些ALL病人来说也许是一种很好的疗法。同种异体移植物将在第15页开始为大家解释。
- Methods The images of lung CT were analyzed in 60 patients with lung complications after allogeneic stem cell transplantation. 方法方法分析总结60例接受骨髓移植术后出现肺部并发症患者的胸部CT资料。
- Graft-versus-host disease (GVHD), an immunologic disease involving multiple organs, often occurs in long-term survivors of allogeneic stem cell transplantation. 移植物抗宿主病是常见于异基因造血干细胞移植术后的一种累及多器官的免疫性疾病。
- The benefit of allogeneic stem cell transplantation for treating blood cancers partly depends on the intensive chemoradiotherapy that is given before stem cell infusion. 异基因造血干细胞移植治疗恶性血液疾病的好处,部分依赖于干细胞输注前的高强度化疗。
- A significant portion of each group (27%) were considered high-risk patients, if they had undergone allogenic stem cell transplantation or had relapsed acute leukemia. 在两个小组中,都有显著比例患者被认为是高危患者(27%25),如他们为异基因移植后或白血病复发的病人。
- CAMIA's antiiral actiity and tolerability were elucidated in a Phase 2 study designed to assess the rate of CM reactiation in patients undergoing allogeneic stem cell transplantation. 2期临床研究期间对CAMIA抗病毒活性和耐受性的评价,是基于对异基因干细胞移植患者CM激活发生率的分析。
- With an allogeneic stem cell transplant, stem cells are taken from a donor and transfused into the patient’s blood after chemotherapy ends. 异基因造血干细胞移植,即是从供者体内采集干细胞,再输入化疗后的患者血液中。
- NAST is developed from theories and ideas of tranditional allogeneic stem cell transplantation,is a new way for hematological diseases ,malignant tumors and congenital immunodeficiencies. 并提出NAST是对传统异基因造血干细胞移植理论和观念的发展及更新,为血液病、恶性肿瘤及免疫、遗传性疾病的治疗开辟了新路径。
- Objective To analyze effects of antithymocyte globulin(ATG) in preventing the occurrence of graft-versus-host disease(GVHD) in allogeneic stem cells transplantation. 目的分析异体造血干细胞移植前加用抗T淋巴细胞球蛋白(ATG)预防移植物抗宿主反应(GVHD)的疗效。
- allogeneic stem cell transplantation 同种异基因造血干细胞移植
- allogene stem cell 异基因干细胞
- The precursor or stem cell of a plasma cell. 成浆细胞浆细胞的前体细胞或干细胞